TIAA-CREF Individual & Institutional Services
FATE icon

TIAA-CREF Individual & Institutional Services’s Fate Therapeutics FATE Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.7K Hold
17,592
– – ﹤0.01% 771
2026
Q2 		$47.5K Hold
17,592
– – ﹤0.01% 742
2026
Q1 		$21.1K Buy
+17,592
New +$21.4K ﹤0.01% 701

Other funds holding FATE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's FATE Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services held its Fate Therapeutics (FATE) position steady in Q3 2026 at 17,592 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

TIAA-CREF Individual & Institutional Services first reported a position in FATE in Q1 2026 and has held it in 3 quarters since. The position peaked at $47.5K in Q2 2026. 101 funds tracked by Wall St. Rank hold FATE as of Q3 2026.

  • TIAA-CREF Individual & Institutional Services held 17,592 shares of Fate Therapeutics worth $41.7K as of Q3 2026.
  • TIAA-CREF Individual & Institutional Services left its Fate Therapeutics share count unchanged in Q3 2026.
  • Fate Therapeutics made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #771 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in Fate Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • TIAA-CREF Individual & Institutional Services's Fate Therapeutics position peaked at $47.5K in Q2 2026.
  • 101 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.